decad
ago
novel
human
coronaviru
term
sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
larg
epidem
case
fatal
rate
creat
worldwid
panic
econom
anoth
novel
coronaviru
term
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
middl
merscov
infect
result
sarslik
diseas
multiorgan
novemb
inform
confirm
case
includ
death
case
fatal
rate
report
cluster
occur
among
famili
contact
healthcar
set
indic
persontoperson
transmiss
close
contact
rais
concern
pandem
therefor
essenti
identifi
drug
target
life
cycl
merscov
turn
develop
antim
therapeut
treat
patient
merscov
infect
combat
potenti
pandem
merscov
envelop
positivesens
singlestrand
rna
viru
genom
size
kb
ref
belong
lineag
c
betacoronaviru
famili
coronavirida
within
order
nidoviral
genet
closer
bat
coronavirus
nonetheless
broader
anim
speci
human
tissu
tropism
suggest
jump
interspeci
barrier
caus
human
infect
although
origin
still
similar
sarscov
merscov
bind
host
cell
interact
receptorbind
domain
spike
protein
receptor
dipeptidyl
also
known
hypothes
subunit
merscov
would
chang
conform
insert
fusion
peptid
target
cell
membran
form
sixbundl
fusion
core
heptad
repeat
domain
subunit
thu
bring
viral
cell
membran
close
apposit
facilit
fusion
turn
releas
viral
genet
materi
hypothesi
proven
could
serv
target
develop
merscov
fusion
inhibitor
like
hiv
infect
peptid
enfuvirtid
solv
crystal
structur
form
merscov
protein
domain
base
structur
design
sever
peptid
span
sequenc
respect
find
one
peptid
potent
inhibit
merscov
infect
proteinmedi
fusion
introduct
glu
ly
arg
residu
lead
increas
stabil
solubl
antimerscov
activ
suggest
peptid
develop
effect
mer
therapeut
ncbi
obtain
fulllength
aminoacid
sequenc
merscov
protein
genbank
whose
subunit
contain
multipl
sequenc
align
sarscov
protein
ntermin
fusion
peptid
fp
residu
domain
residu
domain
residu
transmembran
domain
residu
intracellular
domain
residu
fig
understand
structur
basi
interact
region
merscov
fusion
protein
contain
major
part
residu
residu
short
linker
sggrgg
fig
construct
crystallograph
studi
compar
sarscov
two
function
zone
possess
moder
homolog
amino
acid
ratio
respect
fig
residu
posit
e
g
posit
helix
particip
interact
anoth
helix
helix
respect
well
posit
helix
involv
interact
helic
fig
label
peptid
fig
crystal
structur
show
canon
structur
fig
take
rodlik
shape
length
diamet
merscov
protein
fusion
core
contain
parallel
trimer
coil
coil
three
helic
grey
fig
around
three
helic
entwin
green
fig
obliqu
antiparallel
manner
helic
constitut
form
residu
domain
residu
domain
respect
addit
residu
fold
oneturn
helix
ctermin
fusion
protein
predict
interact
one
helix
two
adjac
helic
predominantli
hydrophob
consist
previous
determin
fusion
core
structur
three
deep
hydrophob
groov
clamp
two
adjac
helic
becom
bind
site
three
helic
fig
although
notabl
differ
length
observ
helic
turn
versu
turn
n
ctermin
tail
region
pack
orderli
manner
hydrophob
groov
central
threehel
coil
coil
mainli
hydrophob
interact
involv
ntermin
portion
ctermin
portion
helix
fig
hydrophil
interact
one
helix
two
neighbour
helic
consist
hydrogen
bond
mostli
distribut
region
around
n
ctermin
end
helic
fig
around
ntermin
portion
helix
form
four
hydrogen
bond
fuse
helix
adjac
helix
around
ctermin
portion
helix
form
hydrogen
bond
fuse
helix
adjac
helix
rel
concentr
hydrogen
bond
constitut
two
anchor
point
end
one
short
helix
call
ncap
ccap
conform
stabil
bind
central
hydrophob
groov
studi
fusion
core
structur
five
coronavirus
includ
sarscov
mhv
tgev
compar
core
structur
merscov
sarscov
mhv
sinc
fusion
core
structur
tgev
avail
pdb
fusion
core
merscov
adopt
similar
fold
sarscov
fig
differ
mhv
fig
mhv
structur
singleturn
could
observ
ntermin
region
could
found
merscov
coronavirus
structur
segment
form
regular
helic
pack
central
core
especi
ctermin
region
quit
differ
merscov
contrast
core
structur
merscov
protein
could
superimpos
sarscov
protein
root
mean
squar
deviat
atom
three
helic
fig
besid
helic
n
ctermin
tail
region
share
similar
conform
merscov
sarscov
indic
tail
region
interact
hydrophob
groov
conserv
manner
addit
highli
conserv
demonstr
interact
display
crystal
structur
determin
stabil
design
synthes
two
individu
peptid
design
overlap
region
involv
interact
domain
crystal
structur
fig
sinc
nativ
polyacrylamidegel
electrophoresi
npage
nondenatur
condit
success
use
test
format
core
structur
class
fusion
use
npage
investig
whether
could
interact
form
similar
peptid
sarscov
protein
alon
show
band
gel
lane
fig
supplementari
fig
sinc
carri
net
posit
charg
thu
move
gel
nativ
electrophoresi
condit
alon
exhibit
band
lower
posit
gel
lane
fig
supplementari
fig
mixtur
show
new
band
upper
posit
gel
lane
fig
supplementari
fig
expect
oligomer
complex
form
howev
could
judg
whether
oligomer
complex
sinc
migrat
speed
molecul
complex
npage
depend
net
charg
size
report
complex
form
sarscov
stabl
condit
without
heat
sampl
accordingli
analys
peptid
well
mixtur
use
sd
polyacrylamid
protein
gel
next
gel
amersco
result
show
migrat
gel
locat
correspond
molecular
weight
kda
complex
migrat
posit
correspond
molecular
mass
kda
theoret
mass
form
kda
fig
supplementari
fig
result
therefor
suggest
could
interact
form
circulardichro
cd
spectroscopi
use
investig
secondari
structur
well
complex
determin
thermal
stabil
complex
shown
fig
display
random
coil
structur
wherea
exhibit
rel
low
phosphat
buffer
ph
mixtur
equimolar
concentr
show
helic
complex
character
saddleshap
neg
peak
far
uv
region
cd
spectrum
minima
nm
remark
increas
molar
ellipt
nm
helic
bundl
show
strong
thermal
stabil
phosphat
buffer
tm
fig
similar
sarscov
complex
togeth
crystal
structur
inform
result
confirm
peptid
deriv
domain
merscov
protein
could
use
form
mimic
fusion
core
structur
vitro
therefor
complex
provid
use
model
basi
studi
detail
structur
merscov
core
design
candid
merscov
fusion
inhibitor
determin
whether
peptid
abl
inhibit
merscov
fusion
target
cell
develop
merscov
proteinmedi
fusion
assay
use
cell
instantan
express
merscov
protein
egfp
effector
cell
cell
express
receptor
merscov
target
cell
cell
express
egfp
includ
control
cell
cell
cocultur
h
number
cell
fuse
cell
count
percent
inhibit
peptid
merscov
proteinmedi
fusion
calcul
see
method
found
cell
could
fuse
cell
absenc
merscov
protein
express
could
effect
fuse
cell
fusion
cell
significantli
block
fig
merscov
proteinmedi
fusion
earli
stage
h
could
observ
invert
microscop
visibl
light
fig
fortyeight
hour
later
mani
cell
could
fuse
cell
form
big
syncytia
could
easili
observ
fluoresc
light
microscop
fig
syncytium
shown
cell
cocultur
cell
peptid
present
cell
cocultur
fig
compar
inhibitori
activ
peptid
peptid
peptid
deriv
region
sarscov
protein
merscov
smediat
fusion
shown
fig
exhibit
signific
inhibitori
activ
concentr
show
potent
inhibitori
effect
result
suggest
could
specif
interact
viral
domain
form
heterolog
block
viral
fusion
core
format
result
inhibit
merscov
proteinmedi
membran
fusion
test
potenti
inhibitori
activ
peptid
antihiv
peptid
antisarscov
peptid
control
merscov
replic
vero
cell
express
ref
shown
fig
could
significantli
inhibit
merscov
replic
vero
cell
dosedepend
manner
valu
peptid
exhibit
signific
inhibit
concentr
result
suggest
could
specif
inhibit
merscov
infect
target
domain
subunit
protein
test
inhibitori
activ
peptid
human
lung
adenocarcinoma
cell
line
hfl
cell
embryon
lung
fibroblast
cell
line
notabl
could
inhibit
merscov
infect
cell
manner
equal
observ
vero
cell
peptid
much
less
effect
inhibit
merscov
infect
hfl
cell
fig
suggest
merscov
may
enter
cell
differ
pathway
therebi
differ
sensit
fusion
inhibitor
peptid
enter
differ
target
cell
merscov
could
inhibit
sarscov
pseudoviru
infect
cell
concentr
high
sarscov
peptid
effect
inhibit
sarscov
infect
fig
indic
peptid
merscovspecif
fusion
inhibitor
use
timeofaddit
assay
found
lost
antimerscov
activ
h
addit
viru
cell
supplementari
fig
suggest
test
may
target
earli
stage
viru
entri
fusion
viral
envelop
target
cell
membran
support
evid
highli
effect
inhibit
merscov
proteinmedi
fusion
fig
syncytium
format
fig
test
potenti
cytotox
peptid
vero
cell
use
viral
inhibit
assay
studi
supplementari
fig
neither
peptid
signific
cytotox
cell
concentr
select
index
suggest
effect
merscov
fusion
inhibitor
low
vitro
toxic
effect
merscov
protein
contain
long
sequenc
shorter
sequenc
fig
peptid
contain
amino
acid
length
similar
lack
antimerscov
activ
fig
possibl
short
therefor
synthes
medium
long
peptid
residu
express
long
peptid
residu
also
synthes
longer
peptid
residu
shorter
peptid
residu
fig
compar
secondari
structur
individu
peptid
found
peptid
form
structur
helic
neither
could
form
structur
supplementari
fig
interestingli
peptid
conform
helic
peptid
peptid
exhibit
random
structur
pb
supplementari
fig
complex
complex
slightli
higher
complex
complex
complex
significantli
higher
complex
notabl
tm
valu
complex
complex
complex
higher
complex
tm
valu
complex
significantli
higher
complex
tabl
confirm
longer
peptid
gener
form
stabl
fusion
core
shorter
result
suggest
peptid
long
enough
form
coil
coil
structur
three
peptid
peptid
short
form
typic
fusion
core
structur
peptid
compar
inhibitori
activ
longer
shorter
peptid
merscov
smediat
fusion
peptid
short
peptid
show
antimerscov
activ
inhibitori
activ
long
peptid
show
margin
improv
peptid
like
peptid
exhibit
inhibitori
activ
merscov
smediat
fusion
supplementari
fig
increas
stabil
solubl
antivir
activ
peptid
mutat
introduc
glu
e
ly
k
residu
arrang
use
similar
approach
introduc
two
point
mutat
peptid
includ
e
b
point
mutat
peptid
includ
e
b
c
e
f
c
e
base
crystal
structur
merscov
fusion
core
fig
none
mutat
expect
block
interact
sinc
mutat
residu
locat
posit
helic
wheel
fig
expect
mutat
would
lead
format
saltbridg
arrang
well
format
saltbridg
arrang
introduc
e
k
mutat
expect
increas
hydrophil
thu
enhanc
water
solubl
mutant
expect
significantli
higher
tm
valu
complex
also
higher
complex
tabl
confirm
introduct
saltbridg
could
increas
stabil
helic
peptid
solubl
increas
respect
inhibitori
activ
merscov
smediat
fusion
increas
respect
tabl
result
consist
obtain
otaka
et
suggest
approach
also
use
design
peptid
improv
stabil
solubl
antimerscov
activ
recent
outbreak
sarslik
diseas
high
fatal
rate
caus
novel
coronaviru
merscov
rais
global
concern
pandem
call
understand
fusion
entri
mechan
order
develop
merscov
fusionentri
inhibitor
therapeut
treatment
merscov
infect
base
previou
experi
research
sarscov
fusion
studi
structur
function
domain
protein
subunit
merscov
particularli
fusion
core
form
domain
order
elucid
viral
fusion
mechan
aim
design
novel
candid
merscov
fusion
inhibitor
construct
fusion
protein
success
gener
crystal
solv
canon
structur
fig
base
crystal
structur
found
region
span
residu
domain
respect
mainli
particip
interact
manner
similar
domain
protein
sarscov
coronavirus
fig
synthes
two
peptid
character
complex
biophys
experi
notic
peptid
could
form
strong
thermal
stabil
confirm
could
interact
form
stabl
core
structur
base
fusion
model
sarscov
addit
result
obtain
studi
propos
model
plasma
membran
fusion
elucid
fusogen
mechan
mediat
merscov
protein
supplementari
fig
earli
jiang
et
wild
et
discov
synthet
peptid
deriv
domain
highli
potent
hiv
fusion
inhibitor
one
peptid
brand
name
fuzeon
gener
name
enfuvirtid
licens
us
fda
treatment
hiv
found
peptid
deriv
domain
sarscov
protein
exhibit
moder
antisarscov
activ
xu
et
tripet
et
solv
crystal
structur
form
peptid
deriv
sarscov
protein
show
whether
peptid
antivir
activ
test
potenti
inhibitori
activ
peptid
merscov
proteinmedi
fusion
merscov
replic
found
peptid
potent
inhibit
merscov
proteinmedi
fusion
syncytium
format
could
also
effect
inhibit
merscov
replic
vero
cell
potent
peptid
sarscov
replic
vero
gener
antivir
activ
peptid
envelop
viru
class
membran
fusion
protein
correl
length
peptid
longer
sequenc
tend
exhibit
better
antivir
present
studi
found
peptid
amino
acid
exhibit
antimerscov
activ
peptid
amino
acid
show
margin
improv
inhibitori
activ
peptid
howev
sinc
much
difficult
expens
synthes
peptid
peptid
select
peptid
develop
like
peptid
deriv
env
envelop
virus
class
fusion
none
merscov
peptid
exhibit
antimerscov
activ
possibl
isol
peptid
automat
form
activ
trimer
tendenc
aggreg
physiolog
absenc
peptid
exposur
hydrophob
interfac
fig
howev
peptid
may
becom
activ
form
trimer
conjug
trimer
motif
foldon
previous
demonstr
peptid
deriv
lack
activ
wherea
foldon
motif
ad
c
terminu
possess
highli
potent
one
may
question
peptid
deriv
domain
merscov
protein
effect
inhibit
merscov
infect
peptid
protect
sarscov
infect
one
explan
like
merscov
enter
host
cell
primarili
plasma
membran
fusion
sarscov
get
target
cell
perhap
mainli
via
endosom
membran
fusion
chan
et
observ
syncyti
format
promin
merscovinfect
cell
cultur
found
sarscovinfect
cell
cultur
studi
cocultur
cell
express
merscov
protein
cell
carri
exhibit
signific
fusion
syncyti
format
fig
chan
et
also
shown
human
lung
adenocarcinoma
cell
line
embryon
lung
fibroblast
cell
line
hfl
highli
suscept
merscov
infect
interestingli
howev
merscovinfect
form
signific
syncytia
wherea
merscovinfect
hfl
cell
suggest
merscov
may
enter
cell
differ
pathway
present
studi
test
inhibitori
activ
peptid
hfl
cell
found
could
inhibit
merscov
infect
cell
effect
vero
cell
less
effect
inhibit
merscov
infect
hfl
cell
find
suggest
merscov
enter
vero
cell
mainli
plasma
membran
fusion
rout
result
particularli
sensit
inhibit
merscov
fusion
inhibitor
viru
might
enter
hfl
cell
mainli
via
endocytosi
rout
henc
would
rel
resist
blockad
peptid
gierer
et
show
merscov
protein
activ
type
ii
transmembran
serin
proteas
endosom
cathepsin
shirato
et
demonstr
simultan
treatment
cathepsin
l
inhibitor
complet
block
viru
entri
cell
indic
merscov
employ
cell
surfac
endosom
pathway
infect
cell
uptak
viru
endosom
merscov
protein
activ
phdepend
cystein
proteas
cathepsin
l
therefor
cathepsin
l
inhibitor
expect
stop
lysosom
entri
viru
uptak
endocytosi
activ
protein
close
cell
surfac
inhibitor
may
stop
uptak
direct
fusion
viral
cytoplasm
membran
sinc
fusion
depend
direct
membran
fusion
without
preced
endocytoisi
endosom
uptak
expect
cathepsin
l
inhibitor
interfer
fusion
inhibitor
may
therefor
interest
determin
whether
cell
typespecif
differ
suscept
inhibit
fusion
inhibitor
correl
differ
suscept
inhibit
cathepsin
l
inhibitor
well
fusion
inhibitor
compar
core
structur
merscov
sarscov
protein
note
obviou
differ
critic
residu
protein
sequenc
might
influenc
detail
interact
first
residu
domain
merscov
abl
form
hydrogen
bond
may
increas
stabil
howev
correspond
residu
domain
sarscov
subunit
pdb
id
incap
form
strong
interact
supplementari
fig
second
bind
domain
merscov
subunit
stronger
domain
sarscov
subunit
respect
supplementari
fig
suggest
two
hydrogen
bond
merscov
subunit
provid
forc
stabil
helix
third
hydrogen
bond
merscov
correspond
residu
sarscov
unabl
form
intermolecular
hydrogen
bond
supplementari
fig
find
suggest
associ
viral
domain
merscov
may
stronger
found
sarscov
consequ
peptid
merscov
may
higher
bind
affin
henc
higher
antivir
activ
correspond
peptid
sarscov
subunit
base
crystal
structur
merscov
peptid
could
modifi
order
improv
stabil
solubl
antivir
activ
use
similar
approach
describ
otaka
et
introduc
ek
mutat
includ
form
intramolecular
saltbridg
thu
design
synthes
two
mutant
mutat
respect
could
form
intramolecular
saltbridg
arrang
fig
inde
complex
peptid
stabl
peptid
watersolubl
higher
peptid
respect
antimerscov
activ
moder
improv
tabl
result
consist
obtain
otaka
et
found
peptid
ek
mutat
display
significantli
improv
stabil
water
solubl
moder
improv
activ
compar
wildtyp
peptid
confirm
approach
also
use
improv
stabil
solubl
antivir
activ
peptid
deriv
merscov
protein
nevertheless
approach
replac
natur
amino
acid
peptid
nonnatur
amino
acid
exampl
damino
acid
addit
cholesterol
fatti
acid
may
also
use
extend
halflif
merscov
peptid
consid
current
absenc
specif
antimerscov
analogu
improv
antimerscov
activ
could
develop
fasttrack
viral
entri
inhibitorbas
antimerscov
drug
clinic
use
treat
patient
merscov
infect
much
like
antihiv
peptid
enfuvirtid
treatment
hiv
howev
unlik
use
mani
month
year
treat
hiv
infect
necessari
administ
merscov
entri
inhibitor
short
period
earli
stage
merscov
infect
amelior
infect
save
live
cell
line
vero
obtain
atcc
manassa
va
usa
cell
line
cell
bank
chines
academi
scienc
shanghai
china
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
express
fusion
protein
nucleotid
sequenc
encod
merscov
region
residu
attach
end
region
residu
short
linker
sggrgg
overlap
pcr
previous
describ
construct
sarscov
ref
whole
sequenc
subclon
vector
artifici
sumotag
e
coli
cell
induc
mm
iptg
incub
overnight
purifi
ninta
affin
resin
qiagen
valencia
ca
usa
hissumotag
cleav
enzym
h
purifi
appli
onto
gel
filtrat
column
ge
healthcar
piscataway
nj
usa
fraction
contain
trimer
collect
concentr
fusion
protein
crystal
use
hang
drop
vapordiffus
method
crystal
grown
silicon
cover
clip
equilibr
mixtur
contain
protein
solut
mg
trimer
mm
ph
mm
nacl
reservoir
solut
hepe
naoh
ph
wv
reservoir
solut
week
singl
crystal
form
flashfrozen
liquid
nitrogen
futur
data
collect
inhous
institut
biophys
chines
academi
scienc
xray
sourc
micromax
gener
rigaku
japan
combin
varimax
hr
optic
rigaku
japan
crystal
k
diffract
resolut
wavelength
nativ
set
xray
diffract
data
collect
raxi
iv
detector
rigaku
japan
exposur
time
min
per
imag
index
process
use
ref
space
group
collect
data
set
molecular
replac
perform
phenixphas
solv
phase
problem
use
sarscov
protein
core
structur
pdb
code
search
final
model
manual
adjust
coot
refin
data
collect
statist
refin
statist
given
tabl
coordin
deposit
rcsb
protein
data
bank
pdb
code
merscov
peptid
includ
residu
residu
residu
residu
residu
shorter
peptid
residu
fig
sarscov
peptid
residu
peptid
residu
synthes
standard
solidphas
peptid
found
pure
high
perform
liquid
chromatographi
hplc
identifi
laser
desorpt
mass
spectrometri
persept
biosystem
framingham
usa
secondari
structur
peptid
determin
cd
spectroscopi
previous
individu
peptid
peptid
mixtur
dilut
phosphat
buffer
mm
sodium
phosphat
ph
final
concentr
cd
spectra
acquir
spectropolarimet
jasco
inc
japan
cd
data
present
mean
residu
ellipt
valu
deg
taken
correspond
thermal
denatur
monitor
nm
applic
thermal
gradient
melt
curv
smooth
midpoint
thermal
unfold
transit
tm
valu
calcul
jasco
softwar
util
nativ
npage
conduct
previous
equimolar
mixtur
peptid
phosphat
buffer
ph
incub
min
addit
trisglycin
nativ
sampl
buffer
tiandz
inc
china
mixtur
load
trisglycin
gel
tricin
glycin
run
buffer
ph
gel
electrophoresi
carri
constant
v
room
temperatur
h
stain
coomassi
blue
imag
visual
fluorchem
imag
system
alpha
innotechproteinsimpl
santa
clara
ca
usa
sodium
dodecyl
sulphat
polyacrylamid
gel
electrophoresi
perform
measur
molecular
mass
peptid
individu
peptid
equimolar
mixtur
peptid
dissolv
pb
incub
room
temperatur
sampl
dilut
volum
laemmli
sampl
load
onto
next
gel
amresco
solon
oh
usa
run
v
min
room
temperatur
track
dye
reach
bottom
edg
gel
gel
stain
coomassi
blue
merscov
proteinmedi
fusion
assess
use
method
similar
determin
envmedi
briefli
cell
transfect
plasmid
paaviresegfp
encod
egfp
paaviresmersegfp
encod
merscov
protein
egfp
cultur
dmem
contain
fb
h
cell
express
merscov
receptor
incub
plate
h
follow
addit
cell
respect
absenc
presenc
test
peptid
grade
indic
concentr
cocultur
h
cell
cell
use
neg
control
fuse
unfus
cell
count
invert
fluoresc
microscop
nikon
eclips
ti
fuse
cell
much
larger
least
twofold
unfus
cell
intens
fluoresc
fuse
cell
weaker
unfus
cell
result
diffus
egfp
one
cell
two
cell
see
fig
percent
inhibit
fusion
calcul
use
follow
formula
e
repres
fusion
experiment
group
p
repres
fusion
posit
control
group
inhibitor
ad
n
fusion
neg
control
group
cell
replac
cell
concentr
inhibit
calcul
use
calcusyn
softwar
kindli
provid
dr
tc
cocultur
h
syncytium
format
could
observ
invert
microscop
without
fluoresc
fig
syncytia
photograph
record
inhibitori
activ
synthet
peptid
merscov
replic
vero
cell
test
use
previous
describ
method
briefli
tissuecultur
infecti
dose
merscov
mix
equal
volum
peptid
grade
concentr
incub
min
mixtur
inocul
triplic
well
microtit
plate
preform
monolay
vero
cell
incub
h
supernat
remov
fresh
medium
ad
day
infect
cytopath
effect
caus
merscov
replic
assess
mtt
assay
valu
calcul
use
calcusyn
sar
mer
pseudoviru
bear
sarscov
merscov
protein
respect
defect
genom
express
luciferas
report
prepar
cotransfect
cell
plasmid
encod
envdefect
luciferaseexpress
detect
inhibitori
activ
peptid
infect
sar
mer
pseudoviru
cell
cell
per
well
plate
respect
infect
sar
merscov
pseudoviru
presenc
absenc
peptid
indic
concentr
cultur
refe
fresh
medium
h
postinfect
incub
addit
h
cell
wash
pb
lyse
use
lysi
reagent
includ
luciferas
kit
promega
aliquot
cell
lysat
transfer
costar
flatbottom
luminomet
plate
corn
costar
follow
addit
luciferas
substrat
promega
rel
light
unit
determin
immedi
ultra
luminomet
tecan
us
cytotox
peptid
cell
cell
vero
cell
use
test
cell
fusion
merscov
replic
detect
use
cell
count
kit
dojindo
kumamoto
japan
follow
manufactur
instruct
briefli
cell
seed
well
microtit
plate
incub
h
peptid
grade
concentr
ad
incub
day
solut
ad
follow
addit
incub
h
absorb
measur
nm
access
code
structur
coordin
deposit
rcsb
protein
data
bank
access
code
cite
articl
lu
l
et
al
structurebas
discoveri
middl
east
respiratori
syndrom
coronaviru
fusion
inhibitor
nat
commun
doi
